| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Axim Biotechnologies, Inc. (AXIM) has 0 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. AXIM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2024 | Valencia Catalina | President And Director | Buy | 1,086,216 | $0.00 | - | +3.9% | |
| Aug 24, 2022 | Valencia Catalina | 10% Owner | Buy | 3,861,004 | $0.03 | $100,000.00 | +19.5% | |
| Mar 19, 2020 | Huemoeller John Walter II | Chief Executive Officer | Buy | 6,000,000 | $0.00 | - | New |